Dolutegravir-rilpivirine for treating HIV-1 in adults

NHS England has reviewed evidence prepared by NICE and concluded that there is enough evidence to commission dolutegravir-rilpivirine for treating HIV-1 in adults in accordance with the criteria outlined in this document.

Source:

NHS England